Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +46.23%
#2 Pons Pons +35.07%
#3 TENDIES TENDIES +29.98%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +28.90%
#5 Starpower Starpower +28.39%
#6 StonkBroker StonkBroker +24.63%
#7 Mubarak Mubarak +24.35%
#8 SkyAI SkyAI +23.92%
#9 Hyperliquid Hyperliquid +20.74%
#10 PondCoin PondCoin +20.32%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Settings
Language
ENGLISH
Currency
USD
Theme
InDex Pharmaceuticals Holding AB (publ) InDex Pharmaceuticals Holding AB (publ)

InDex Pharmaceuticals Holding AB (publ)

INDEX
Rank in Stocks #28996
InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to... InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to developing therapeutic solutions for patients affected by ulcerative colitis. The company's flagship drug candidate, Cobitolimod, is presently in Phase III clinical trials, targeting the treatment of moderate to severe ulcerative colitis. Furthermore, InDex is progressing a pipeline of other DNA-based immunomodulatory sequences, which are in the preclinical phase, designed to address various immunological conditions. This enterprise was established in 2000 and operates from its headquarters in Solna, Sweden.
Share Price
$0.04406501
Last synced: 2024-07-09
Market Cap
$23.47M
Change (1 day)
-0.48%
Change (1 year)
0.00%
Country
SE
Trade InDex Pharmaceuticals Holding AB (publ) (INDEX)

Category

Healthcare
Earnings for InDex Pharmaceuticals Holding AB (publ) (INDEX)
Earnings in 2026 TTM: 0
According to InDex Pharmaceuticals Holding AB (publ) latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for InDex Pharmaceuticals Holding AB (publ) from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH